In 1964, the US Surgeon General officially declared smoking a health hazard – a turning point in prevention. However, while campaigns were underway, another pattern quietly emerged: Women often bore different, sometimes higher risks for cardiovascular diseases – yet were less frequently diagnosed accurately or treated consistently. Today, we know that sex influences symptoms, biology, and care pathways. Those aiming for high performance and longevity should leverage these differences – not suffer from them.

Heart disease is not just heart disease – and especially not in women. Many women more frequently present with non-obstructive ischemiareduced blood flow to the heart muscle without significant narrowing of vessels, such as MINOCAmyocardial infarction without detectable blockage of the major coronary arteries, SCADspontaneous coronary artery dissection, or coronary microvascular dysfunctiondysfunction of the smallest coronary vessels, which can be easily overlooked in standard tests. Additionally, female risk amplifiers like preeclamptic pregnanciespregnancy complication with high blood pressure, early menopauseloss of hormonal protection before the typical age, or autoimmune diseasesmisguided immune responses, more common in women come into play. Diagnostically, women often report atypical symptoms such as pressure in the chest, back, or jaw, shortness of breath, nausea, and fatigue – not just the "classic" chest pain. If these signals are interpreted through male patterns, there is a risk of misinterpretations and delayed therapies. This is where precision medicine begins: taking symptoms seriously, systematically capturing female risk factors, and tailoring diagnostics to the spectrum of female coronary syndromes ^[1].

The consequences of these differences are concrete – and preventable. Studies show that women are more often classified differently with identical heart symptoms, sometimes focusing on psychological causes. The result is later diagnoses, fewer imaging studies, and less guideline-conforming treatments, which worsen both short-term and long-term prognosis ^{[2] [3]}. Lifestyle factors play a gender-specific role: Physical activity significantly reduces coronary risk for women, often more so than for men; those who meet the recommendations substantially lower their risk ^[4]. Conversely, smoking, obesity, and hypertension particularly accelerate cardiovascular damage in women – leading to a higher risk of stroke and heart failure later in life ^{[5] [6]}. Psychological stress has a dual effect: It increases women's susceptibility to cardiovascular diseases – and heart disease, in turn, raises the risk of depression and anxiety, creating a cycle that hinders recovery ^[7].

More movement, more benefit – especially for women: In a large cohort analysis using accelerometers, adherence to 150 minutes of moderate-intensity activity per week was associated with a 22 percent lower risk of coronary heart disease (CHD) in women; notably, women achieved around a 30 percent risk reduction with only about 250 minutes per week, while men required significantly more time. Among those already affected, the survival advantage from activity was also greater for women. This supports the need for gender-specific tailored prevention programs and for wearables as motivational and management tools ^[4]. Insufficient movement leaves traces in the heart muscle long before disease becomes visible: In a population-based long-term cohort, repeated inactivity was associated with subtly poorer myocardial deformation values on cardiac MRI – an early marker for functional loss. These data emphasize that lack of exercise promotes structural changes long before symptoms develop ^[8]. Another driver is nicotine – particularly toxic in women: An analysis from the Women’s Health Initiative showed that smoking leaves profound epigenetic changes in women. Such DNA methylation patterns predicted cardiovascular and overall mortality even better than self-reported pack-years. This underscores how profoundly tobacco biologically shapes women's cardiovascular systems – and how vital effective cessation is ^[9]. Concurrently, a narrative review on ischemic heart disease indicates that women less frequently receive adequate diagnostics (such as imaging) and therapy (PCI, statins) and more often suffer from non-obstructive forms like MINOCA and SCAD. This demands clear, gender-specific diagnostic pathways and rehabilitation offers that consistently reach women ^[3].

- Dose movement like medication: Aim for 150 minutes of moderate-intensity activity per week (e.g., brisk walking, cycling). Women tend to benefit disproportionately; 250 minutes per week can reduce CHD risk by about 30% ^[4]. Start with 5×30 minutes or incorporate 3×10 minutes into your daily routine.
- Activate daily life: Wear a wearable and set weekly activity goals. Use "Guideline-Adherence Days" as a playful KPI – proven to have a health-relevant effect ^[4].
- Tackle smoking cessation strategically: Combine behavioral therapy programs with nicotine replacement or varenicline following medical advice. In women, the cardiovascular damage from tobacco is particularly pronounced; every smoke-free week counts – and is also measurable epigenetically ^[9].
- Reset alcohol consumption: If you drink a lot, reduce to mild-moderate levels. In a large cohort, the risk of severe cardiovascular events dropped by 23% after reduction – particularly for angina and ischemic stroke ^[10].
- Manage stress as a performance variable: 10–15 minutes of daily meditation, yoga, or Qigong improve stress regulation, blood pressure, and heart rate variability – factors that are closely linked to heart health in women ^[7]. Incorporate fixed "Mind-Body" slots into your calendar and tracking.
- Think female for medical checks: Specifically address female risk factors (pregnancy complications, early menopause, autoimmunity) and mention atypical symptoms. Request appropriate diagnostics if INOCA/MINOCA/SCAD is suspected (e.g., CMR, intracoronary imaging, functional tests) ^{[1] [3]}.

The data clearly move toward gender-specific precision: Wearable-supported activity goals, stress-regulating interventions, and diagnostic pathways for non-obstructive coronary syndromes could close care gaps. Next research steps: valid thresholds and algorithms for women-specific diagnoses, epigenetic markers for risk stratification, and studies that consistently represent women – ensuring that prevention and therapy reflect actual biology.